Cellular basis for atrial fibrillation in an experimental model of short QT1: Implications for a pharmacological approach to therapy

This publication has 39 references indexed in Scilit:

• How Do Atrial-Selective Drugs Differ From Antiarrhythmic Drugs Currently Used in the Treatment of Atrial Fibrillation?
  Journal of Atrial Fibrillation, 2008
• The pharmacological response of ischemia-related atrial fibrillation in dogs: Evidence for substrate-specific efficacy
  Cardiovascular Research, 2007
• Disopyramide is an effective inhibitor of mutant HERG K+ channels involved in variant 1 short QT syndrome
  Journal of Molecular and Cellular Cardiology, 2006
• Catheter Ablation of Long‐Lasting Persistent Atrial Fibrillation: Critical Structures for Termination
  Journal of Cardiovascular Electrophysiology, 2005
• Further Insights into the Effect of Quinidine in Short QT Syndrome Caused by a Mutation in HERG
  Journal of Cardiovascular Electrophysiology, 2005
• Identification of a KCNE2 Gain-of-Function Mutation in Patients with Familial Atrial Fibrillation
  The American Journal of Human Genetics, 2004
• Transmembrane action potential heterogeneity in the canine isolated arterially perfused right atrium: effect ofI_KrandI_Kur/I_toblock
  American Journal of Physiology-Heart and Circulatory Physiology, 2004
• Sudden Death Associated With Short-QT Syndrome Linked to Mutations in HERG
  Circulation, 2004
• Ionic mechanisms of electrical remodeling in human atrial fibrillation
  Cardiovascular Research, 1999
• Ionic Mechanisms of Regional Action Potential Heterogeneity in the Canine Right Atrium
  Circulation Research, 1998